Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NLR-fat/NLR-muscle mass grading system significantly predicts survival in cancer patients: a multicenter cohort study.

Cancer treatment and research communications·2026
Same author

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota-Dependent Manner.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Nutrition impact symptoms and the risk of malnutrition, frailty, and sarcopenia in adults with cancer: A cross-sectional latent class analysis.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

Contribution of FXR1 genetic polymorphisms to breast cancer susceptibility in Chinese females.

Molecular genetics and genomics : MGG·2026
Same author

A novel autoantibody panel as potential diagnostic markers for hepatocellular carcinoma.

Biomarkers in medicine·2026
Same author

Diagnostic accuracy of PG-SGA, mPG-SGA, and GLIM criteria in malnutrition detection and survival prediction in patients with gastric cancer.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA).

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Brain-Derived Neurotrophic Factor, Sarcopenia and Digital Gait Characteristics in Older Adults: Insights Into the Brain-Muscle Axis.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Functional Outcomes and Quality of Life for Patients With Cachexia and Solid Tumour Cancers: Findings of a Systematic Literature Review.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Comment on 'Asian Reference Values for Handgrip Strength, Gait Speed, Five-Times-Sit-to-Stand Test, Muscle Mass and Calf Circumference' by Grgic et al.-The Authors' Reply.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Deletion of Tgf-β1 From CD206<sup>+</sup> M2 Macrophages Ameliorates Obesity-Induced Suppression of Myogenesis and AMPK Phosphorylation in Skeletal Muscle.

Journal of cachexia, sarcopenia and muscle·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.1K

A Novel Definition and Grading Diagnostic Criteria for Tumour-Type-Specific Comprehensive Cachexia Risk.

Chunlei Hu1,2,3, Minghua Cong4,5, Chunhua Song6

  • 1Department of General Surgery, The First Hospital of Tsinghua University, Tsinghua University, Beijing, China.

Journal of Cachexia, Sarcopenia and Muscle
|March 21, 2025
PubMed
Summary
This summary is machine-generated.

This study developed new cancer cachexia evaluation scales for solid tumours, identifying key nutrition and disease factors. The scales classify cachexia risk, aiding tailored treatment strategies for better patient outcomes.

Keywords:
cancer cachexiacomprehensive cancer cachexia riskdiagnostic criteriasolid tumourtumour‐type‐specific diagnosis

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: May 21, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Oncology
  • Clinical Nutrition
  • Biostatistics

Background:

  • Existing cancer cachexia diagnostic criteria are inadequate for clinical practice.
  • There is a need for comprehensive evaluation scales tailored to patients with solid tumours.

Purpose of the Study:

  • To establish novel, comprehensive evaluation scales for cancer cachexia in solid tumour patients.
  • To develop tumour-type-specific diagnostic criteria for cancer cachexia risk.

Main Methods:

  • A large cohort of 12,651 patients with 14 types of solid tumours was analyzed.
  • Cox proportional hazards models and Kaplan-Meier analysis were used to identify risk factors.
  • Nutrition and disease parameters were assessed to construct weighted scoring scales.

Main Results:

  • A nutrition-weighted scoring scale (NWSS) and a disease-weighted scoring scale (DWSS) were developed.
  • A combined scale classified patients into five cachexia risk categories (A-E), with significant differences in survival.
  • Refractory cachexia (Category E) showed poor response to nutrition and anti-tumour therapies.

Conclusions:

  • A novel definition and grading system for comprehensive cancer cachexia risk were systematically developed.
  • The new criteria are specific to tumour type and provide a five-grade classification of cachexia risk.
  • This framework aims to improve the clinical management of cancer cachexia.